Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Eastnine | EAST | Apr 26, 2024 | 166.00 | +1.82 |
EasyFill B | EASYB | Apr 26, 2024 | 0.20 | +2.63 |
EatGood | EATG | Apr 26, 2024 | 1.00 | +21.95 |
eBlitz Group | EBLITZ | Apr 26, 2024 | 0.38 | 0.00 |
Ecoclime Group B | ECCB | Apr 26, 2024 | 2.24 | +6.16 |
ECOMB | ECOM | Apr 26, 2024 | 0.32 | +3.56 |
EcoRub B | ECOB | Apr 26, 2024 | 0.16 | +3.59 |
Ectin Research | ECTINB | Apr 26, 2024 | 0.46 | -4.96 |
Edyoutec AB | EDYOU | Apr 26, 2024 | 0.63 | -2.01 |
eEducation Albert | ALBERT | Apr 26, 2024 | 3.82 | +4.09 |
Eevia Health | EEVIA | Apr 26, 2024 | 1.54 | +4.05 |
Effnetplattformen Holding | EFFH | Apr 26, 2024 | 4.94 | -1.20 |
Egetis Therapeutics | EGTX | Apr 26, 2024 | 5.75 | -3.20 |
Ekobot | EKOBOT | Apr 26, 2024 | 0.30 | +41.63 |
Elanders B | ELANB | Apr 26, 2024 | 95.00 | +0.21 |
Electrolux A | ELUXA | Apr 26, 2024 | 116.00 | +3.57 |
Electrolux B | ELUXB | Apr 26, 2024 | 95.46 | +6.49 |
Electrolux Professional B | EPROB | Apr 26, 2024 | 69.20 | +2.82 |
Elekta B | EKTAB | Apr 26, 2024 | 75.60 | +2.30 |
Elicera Therapeutics | ELIC | Apr 26, 2024 | 0.95 | +1.06 |
Ellen | ELN | Apr 26, 2024 | 1.23 | -2.38 |
Ellwee | ELLWEE | Apr 26, 2024 | 6.82 | +0.59 |
Elmera Group | ELMRAO | Apr 26, 2024 | 32.90 | 0.00 |
Elon AB (publ) | ELON | Apr 26, 2024 | 28.10 | -1.40 |
Eltel | ELTEL | Apr 26, 2024 | 6.78 | -0.88 |
EmbeddedArt Group AB (publ) | EMART | Apr 26, 2024 | 0.01 | -10.13 |
Embellence Group | EMBELL | Apr 26, 2024 | 23.10 | -2.12 |
Embracer Group B | EMBRACB | Apr 26, 2024 | 27.04 | -2.14 |
Emilshus | EMILPREF | Apr 26, 2024 | 28.40 | 0.00 |
Emilshus B | EMILB | Apr 26, 2024 | 32.80 | -0.30 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.